Lyme disease update

Current Opinion in Pediatrics

Volumn 19, Issue 3, 2007, Pages 275-280

  Hoppa, Eric ^a,b   Bachur, Richard ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b Division of Sleep Medicine   (United States)

Author keywords

Diagnostic test; Lyme disease; Meningitis; Tick related illness

Indexed keywords

ANTIBIOTIC AGENT;

ANAPLASMOSIS; ANTIBIOTIC THERAPY; BORRELIA BURGDORFERI; BORRELIA INFECTION; CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL FEATURE; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INFESTATION; IXODES SCAPULARIS; LONG TERM CARE; LYME DISEASE; MENINGITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SEROLOGY; SKIN BIOPSY; TREATMENT PLANNING;

BORRELIA BURGDORFERI; HUMANS; LYME DISEASE; MENINGITIS, VIRAL;

EID: 34249042370     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e3280e1269a     Document Type: Review

References (46)

1. Lyme disease: United States, 2001-2002. MMWR Morb Mortal Wkly Rep 2004; 53:365-369.
2. Smith R, Takkinen J. Lyme borreliosis: Europe-wide coordinated surveillance and action needed? Euro Surveill 2006; 11:E0606221.
3. Hanincova K, Kurtenbach K, Diuk-Wasser M, et al. Epidemic spread of Lyme borreliosis, northeastern United States. Emerg Infect Dis 2006; 12:604-611.
4. Wormser GP. Clinical practice. Early Lyme disease. N Engl J Med 2006; 354:2794-2801. This is a comprehensive review of the diagnosis, treatment, and controversies of early Lyme disease.
5. Hengge UR, Tannapfel A, Tyring SK, et al. Lyme borreliosis. Lancet Infect Dis 2003; 3:489-500.
6. Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006; 43:1089-1134. This is the most recent publication by the Infectious Disease Society of America on Lyme disease, human granulocytic anaplasmosis, and babesiosis. It includes evidence-based recommendations on the diagnosis, treatment, and prevention of all three conditions.
7. Gerber MA, Shapiro ED, Burke GS, et al. Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group. N Engl J Med 1996; 335:1270-1274.
8. Bingham PM, Galetta SL, Athreya B, Sladky J. Neurologic manifestations in children with Lyme disease. Pediatrics 1995; 96:1053-1056.
9. Eppes SC, Nelson DK, Lewis LL, Klein JD. Characterization of Lyme meningitis and comparison with viral meningitis in children. Pediatrics 1999; 103 (5 Pt 1):957-960.
10. Tuerlinckx D, Bodart E, Garrino MG, de Bilderling G. Clinical data and cerebrospinal fluid findings in Lyme meningitis versus aseptic meningitis. Eur J Pediatr 2003; 162:150-153.
11. Shah SS, Zaoutis TE, Turnquist J, et al. Early differentiation of Lyme from enteroviral meningitis. Pediatr Infect Dis J 2005; 24:542-545.
12. Avery RA, Frank G, Glutting JJ, Eppes SC. Prediction of Lyme meningitis in children from a Lyme disease-endemic region: a logistic-regression model using history, physical, and laboratory findings. Pediatrics 2006; 117:e1-e7. In this study the authors used logistic regression to propose a predictive model to differentiate between Lyme meningitis and aseptic meningitis in children based on the duration of headache, presence of cranial neuritis, and predominance of CSF mononuclear cells.
13. Lyme disease: United States, 1996. MMWR Morb Mortal Wkly Rep 1997; 46:531-535.
14. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep 1995; 44:590-591.
15. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of Lyme borreliosis. Clin Microbiol Rev 2005; 18:484-509.
16. Tugwell P, Dennis DT, Weinstein A, et al. Laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med 1997; 127:1109-1123.
17. Exner MM, Lewinski MA. Isolation and detection of Borrelia burgdorferi DNA from cerebral spinal fluid, synovial fluid, blood, urine, and ticks using the Roche MagNA Pure system and real-time PCR. Diagn Microbiol Infect Dis 2003; 46:235-240.
18. Nocton JJ, Dressler F, Rutledge BJ, et al. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med 1994; 330:229-234.
19. Coulter P, Lema C, Flayhart D, et al. Two-year evaluation of Borrelia burgdorferi culture and supplemental tests for definitive diagnosis of Lyme disease. J Clin Microbiol 2005; 43:5080-5084.
20. Christen HJ, Eiffert H, Ohlenbusch A, Hanefeld F, et al. Evaluation of the polymerase chain reaction for the detection of Borrelia burgdorferi in cerebrospinal fluid of children with acute peripheral facial palsy. Eur J Pediatr 1995; 154:374-377.
21. Huppertz HI, Schmidt H, Karch H. Detection of Borrelia burgdorferi by nested polymerase chain reaction in cerebrospinal fluid and urine of children with neuroborreliosis. Eur J Pediatr 1993; 152:414-417.
22. Lebech AM, Hansen K. Detection of Borrelia burgdorferi DNA in urine samples and cerebrospinal fluid samples from patients with early and late Lyme neuroborreliosis by polymerase chain reaction. J Clin Microbiol 1992; 30:1646-1653.
23. Lebech AM, Hansen K, Brandrup F, et al. Diagnostic value of PCR for detection of Borrelia burgdorferi DNA in clinical specimens from patients with erythema migrans and Lyme neuroborreliosis. Mol Diagn 2000; 5:139-150.
24. Avery RA, Frank G, Eppes SC. Diagnostic utility of Borrelia burgdorferi cerebrospinal fluid polymerase chain reaction in children with Lyme meningitis. Pediatr Infect Dis J 2005; 24:705-708.
25. Pickering L, editor. Lyme disease. In: The Red Book: the 2006 Report of the Committee on Infectious Diseases. Elk Grove Village: American Academy of Pediatrics; 2006. pp. 428-433.
26. Heikkila T, Saxen H, Seppala I, et al. New antigens for serologic diagnosis of neuroborreliosis in children. Pediatr Infect Dis J 2005; 24:709-712.
27. Cooper JD, Feder HM Jr. Inaccurate information about Lyme disease on the internet. Pediatr Infect Dis J 2004; 23:1105-1108.
28. Klempner MS. Controlled trials of antibiotic treatment in patients with posttreatment chronic Lyme disease. Vector Borne Zoonotic Dis 2002; 2:255-263.
29. Klempner MS, Hu LT, Evans J, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 2001; 345:85-92.
30. Klempner MS, Wormser GH, Wade K, et al. A case-control study to examine HLA haplotype associations in patients with posttreatment chronic Lyme disease. J Infect Dis 2005; 192:1010-1013.
31. Weinstein A, Britchkov M. Lyme arthritis and post-Lyme disease syndrome. Curr Opin Rheumatol 2002; 14:383-387.
32. Kaplan RF, Trevino RP, Johnson GM, et al. Cognitive function in posttreatment Lyme disease: do additional antibiotics help? Neurology 2003; 60:916-922.
33. Centers for Disease Control and Prevention. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep 2005; 54:125-126.
34. James AM, Liveris D, Wormser GP, et al. Borrelia lonestari infection after a bite by an Amblyomma americanum tick. J Infect Dis 2001; 183:1810-1814.
35. Philipp MT, Masters E, Wormser GP, et al. Serologic evaluation of patients from Missouri with erythema migrans-like skin lesions with the C6 Lyme test. Clin Vaccine Immunol 2006; 13:1170-1171. This study showed no serologic evidence of Borrelia burgdorferi as the infectious agent in patients from Missouri with STARI.
36. Wormser GP, Masters E, Liveris D, et al. Microbiologic evaluation of patients from Missouri with erythema migrans. Clin Infect Dis 2005; 40:423-428.
37. Taft SC, Miller MK, Wright SM. Distribution of Borreliae among ticks collected from eastern states. Vector Borne Zoonotic Dis 2005; 5:383-389.
38. Wormser GP, Masters E, Nowakowski J, et al. Prospective clinical evaluation of patients from Missouri and New York with erythema migrans-like skin lesions. Clin Infect Dis 2005; 41:958-965.
39. Swanson SJ, Neitzel D, Reed KD, Belongia EA. Coinfections acquired from ixodes ticks. Clin Microbiol Rev 2006; 19:708-727. This is a comprehensive review on the epidemiology, biology, diagnosis, and treatment of co-infections acquired from ixodes ticks.
40. Christova I, Schouls L, van De Pol I, et al. High prevalence of granulocytic Ehrlichiae and Borrelia burgdorferi sensu lato in Ixodes ricinus ticks from Bulgaria. J Clin Microbiol 2001; 39:4172-4174.
41. Krause PJ. Babesiosis. Med Clin North Am 2002; 86:361-373.
42. Krause PJ, Telford SR 3rd, Spielman A, et al. Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness. JAMA 1996; 275:1657-1660.
43. Wormser GP, Horowitz HW, Nowakowski J, et al. Positive Lyme disease serology in patients with clinical and laboratory evidence of human granulocytic ehrlichiosis. Am J Clin Pathol 1997; 107:142-147.
44. Kaltman JR, Tanel RE, Vetter VL, et al. Junctional rhythm in association with neuroborreliosis. Pediatr Emerg Care 2005; 21:850-853.
45. Seslar SP, Berul CI, Burklow TR, et al. Transient prolonged corrected QT interval in Lyme disease. J Pediatr 2006; 148:692-697
46. Pinto DS. Cardiac manifestations of Lyme disease. Med Clin North Am 2002; 86:285-296.